STERIS plc (STE) stock
STENYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 19/300% above fair value
$259.57+2.16 (+0.84%)
Close on Nov 18, 2026Market cap $25.31BP/E 31.7Yield 0.95%
Steris net income
Net income is the profit left for shareholders after every expense, interest and tax.
Steris's net income for the twelve months ending Jun 30, 2026 was $805.10M, up 24.5% year over year. For fiscal 2026 it was $782.30M, up 27.3% from the year before. The highest annual figure on record is $782.30M in fiscal 2026.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $782.30M | +27.3% |
| FY2025 | Mar 31, 2025 | $614.60M | +62.5% |
| FY2024 | Mar 31, 2024 | $378.20M | +253.4% |
| FY2023 | Mar 31, 2023 | $107.03M | -56.1% |
| FY2022 | Mar 31, 2022 | $243.89M | -38.6% |
| FY2021 | Mar 31, 2021 | $397.40M | -2.5% |
| FY2020 | Mar 31, 2020 | $407.66M | +34.2% |
| FY2019 | Mar 31, 2019 | $303.72M | +4.4% |
| FY2018 | Mar 31, 2018 | $290.92M | +164.6% |
| FY2017 | Mar 31, 2017 | $109.97M | – |
Quarterly net income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $200.10M | +12.8% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $220.20M | +51.2% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $192.90M | +11.2% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $191.90M | +27.9% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $177.40M | +22.0% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $145.60M | – |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $173.50M | +23.3% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $150.00M | +30.1% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $145.40M | +17.7% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | -$1.38M | -100.7% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $140.74M | +13.7% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $115.32M | – |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $123.55M | +11.0% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $187.23M | +258.2% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $123.83M | -13.8% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | -$315.29M | -551.6% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $111.26M | – |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $52.26M | -40.2% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $143.62M | +25.4% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $69.81M | -34.1% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | -$21.81M | -124.3% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $87.44M | -28.7% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $114.50M | +9.1% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $105.86M | +11.7% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $89.60M | +5.0% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $122.59M | +12.7% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $104.93M | +119.3% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $94.77M | +22.4% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $85.37M | +22.0% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $108.75M | +47.8% |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $47.86M | -49.5% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $77.46M | +1113.7% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $69.99M | +20.5% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $73.60M | – |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $94.78M | – |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $6.38M | – |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $58.08M | – |
See a number that looks wrong?